Literature DB >> 3505197

Purification of bone alkaline phosphatase from human osteosarcoma.

K Masuhara1, K Sugamoto, H Yoshikawa, K Takaoka, K Ono, D C Morris, H H Hsu, H C Anderson.   

Abstract

Purification of human bone alkaline phosphatase, derived from human osteosarcoma tissue, has been carried to electrophoretic homogeneity. The purification procedure involved three major steps: (1) chromatography on hydroxylapatite; (2) ion exchange chromatography; and (3) gel filtration. The resultant purified enzyme is a glycoprotein, has a molecular weight of approximately 80,000 (consistent with previous reports for the bone isoenzyme), and is characteristically inhibited by modest heat (56 degrees C, 30 min) and L-homoarginine but not by L-phenylalanine. The isolation and purification procedure described can lead to the production of significant amounts of highly purified bone alkaline phosphatase. Purified ALP can be used for an analysis of minor structural differences that appear to exist between the bone, liver and kidney isoenzymes. Such information could lead to the development of a clinical diagnostic procedure specifically for bone alkaline phosphatase.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3505197

Source DB:  PubMed          Journal:  Bone Miner        ISSN: 0169-6009


  3 in total

1.  Monoclonal antibody against human bone alkaline phosphatase.

Authors:  K Masuhara; R Yoshikawa; K Takaoka; K Ono; D C Morris; H C Anderson
Journal:  Int Orthop       Date:  1991       Impact factor: 3.075

2.  Expression of collagen, osteocalcin, and bone alkaline phosphatase in a mineralizing rat osteoblastic cell culture.

Authors:  P Collin; J R Nefussi; A Wetterwald; V Nicolas; M L Boy-Lefevre; H Fleisch; N Forest
Journal:  Calcif Tissue Int       Date:  1992-02       Impact factor: 4.333

3.  Kinetic comparison of tissue non-specific and placental human alkaline phosphatases expressed in baculovirus infected cells: application to screening for Down's syndrome.

Authors:  Colette C Denier; Andrée A Brisson-Lougarre; Ghislaine G Biasini; Jean J Grozdea; Didier D Fournier
Journal:  BMC Biochem       Date:  2002-01-15       Impact factor: 4.059

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.